Search Tag: Endogenex™
2023 18 May
Bringing expertise in diabetes management medical and regulatory affairs, clinical research, and market access Endogenex, Inc., a clinical stage medical device company, is proud to announce the addition of Christopher Sorli, MD, PhD, as Chief Medical Officer (CMO). Dr. Sorli brings a wealth of experience and clinical expertise to the company’s...Read more
2023 23 Mar
Endogenex, Inc., a clinical stage medical device company, is proud to announce the addition of Stacey Pugh as Chief Executive Officer (CEO). In this role Stacey will lead the organization as it expands its clinical initiatives evaluating the novel ReCET™ Procedure for the treatment of Type 2 Diabetes. "We are thrilled to have Stacey join the Endogenex...Read more